TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›MRAI›Financials
Annual statements · SEC XBRL · FY2020 – FY2025

Marpai, Inc. (MRAI) financials

Income statement

Marpai, Inc. (MRAI) income statement, annual, from SEC filings
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
Revenue—$14.2M$24.3M$37.2M$28.2M$18.1M
Revenue growth——71.1%52.6%-24.2%-35.8%
Operating income-$3.37M-$15.9M-$27.0M-$28.0M-$22.1M-$13.6M
Operating margin—-111.5%-110.7%-75.3%-78.4%-74.9%
Net income-$3.87M-$16.0M-$26.5M-$28.8M-$22.1M-$16.6M
Net margin—-112.4%-108.7%-77.4%-78.4%-91.5%
EPS (diluted)-$1.60-$1.59-$5.23-$4.14-$1.92-$0.95

Cash flow

Marpai, Inc. (MRAI) cash flow, annual, from SEC filings
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow-$1.95M-$10.8M-$35.2M-$15.7M-$15.2M-$7.45M
Capital expenditures$30.7K$273K$363K———
Free cash flow-$1.98M-$11.1M-$35.6M———

Balance sheet

Marpai, Inc. (MRAI) balance sheet, annual, from SEC filings
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$1.75M$19.2M$13.8M$1.15M$764K$133K
Total assets$6.53M$44.2M$49.9M$31.7M$12.9M$10.9M
Total liabilities$10.0M$14.5M$43.8M$45.1M$40.6M$43.5M
Long-term debt—$0.00$20.2M$19.4M$17.8M$11.4M
Shareholders' equity-$3.50M$29.7M$6.13M-$13.4M-$27.7M-$32.6M
Retained earnings-$5.54M-$21.5M-$48.0M-$76.7M-$98.8M-$115M
Shares (wtd avg diluted)2.43M10.1M5.06M6.95M11.5M17.4M

Every figure is extracted from Marpai, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is Marpai, Inc.'s annual revenue?
Marpai, Inc. (MRAI) reported $18.1M of revenue for fiscal year 2025 — down 35.8% from $28.2M in FY2024, per its annual report filed with the SEC.
Is Marpai, Inc. profitable?
Not in FY2025 — MRAI reported a net loss of $16.6M, per SEC filings.
Does MRAI pay a dividend?
Marpai, Inc. reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full MRAI analysis — verdict, score & filings →Is MRAI a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.